Inflammatory biomarkers are used to guide severe asthma therapy and may also identify activation of underlying inflammatory pathways. We examined biomarker profiles [immunoglobin E (IgE), blood eosinophils, and fractional exhaled nitric oxide (FeNO)] in a severe asthma cohort by employing both conventional cut-off values and cluster analysis.
|Publication status||Accepted/In press - 19 Mar 2020|
|Event||Respiratory Effectiveness Group Summit 2020 - |
Duration: 19 Mar 2020 → 21 Mar 2020
|Conference||Respiratory Effectiveness Group Summit 2020|
|Period||19/03/20 → 21/03/20|